Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 63

1.

Effect of Enterococcus faecalis 2001 on colitis and depressive-like behavior in dextran sulfate sodium-treated mice: involvement of the brain-gut axis.

Takahashi K, Nakagawasai O, Nemoto W, Odaira T, Sakuma W, Onogi H, Nishijima H, Furihata R, Nemoto Y, Iwasa H, Tan-No K, Tadano T.

J Neuroinflammation. 2019 Oct 31;16(1):201. doi: 10.1186/s12974-019-1580-7.

2.

Role of prefrontal cortical 5-HT2A receptors and serotonin transporter in the behavioral deficits in post-pubertal rats following neonatal lesion of the ventral hippocampus.

Mitazaki S, Nakagawasai O, Onogi H, Watanabe K, Takahashi K, Tan-No K, Quirion R, Srivastava LK, Tadano T.

Behav Brain Res. 2020 Jan 13;377:112226. doi: 10.1016/j.bbr.2019.112226. Epub 2019 Sep 12.

PMID:
31521737
3.

Prenatal treatment with methylazoxymethanol acetate as a neurodevelopmental disruption model of schizophrenia in mice.

Takahashi K, Nakagawasai O, Sakuma W, Nemoto W, Odaira T, Lin JR, Onogi H, Srivastava LK, Tan-No K.

Neuropharmacology. 2019 May 15;150:1-14. doi: 10.1016/j.neuropharm.2019.02.034. Epub 2019 Mar 1.

PMID:
30831160
4.

CDK9 Inhibitor FIT-039 Suppresses Viral Oncogenes E6 and E7 and Has a Therapeutic Effect on HPV-Induced Neoplasia.

Ajiro M, Sakai H, Onogi H, Yamamoto M, Sumi E, Sawada T, Nomura T, Kabashima K, Hosoya T, Hagiwara M.

Clin Cancer Res. 2018 Sep 15;24(18):4518-4528. doi: 10.1158/1078-0432.CCR-17-3119. Epub 2018 Apr 30.

5.

A Report on Nursing Information During Volunteer Activities Conducted by Nursing Faculty Members and Students After the Great East Japan Earthquake.

Tomizawa Y, Ichinose M, Onogi H, Suzuki C, Nakamura R, Misawa S.

Stud Health Technol Inform. 2016;225:1060-1.

PMID:
27332483
6.

BE360, a new selective estrogen receptor modulator, produces antidepressant and antidementia effects through the enhancement of hippocampal cell proliferation in olfactory bulbectomized mice.

Nakagawasai O, Nemoto W, Onogi H, Moriya T, Lin JR, Odaira T, Yaoita F, Ogawa T, Ohta K, Endo Y, Tan-No K.

Behav Brain Res. 2016 Jan 15;297:315-22. doi: 10.1016/j.bbr.2015.10.033. Epub 2015 Oct 20.

PMID:
26497104
7.

Rectifier of aberrant mRNA splicing recovers tRNA modification in familial dysautonomia.

Yoshida M, Kataoka N, Miyauchi K, Ohe K, Iida K, Yoshida S, Nojima T, Okuno Y, Onogi H, Usui T, Takeuchi A, Hosoya T, Suzuki T, Hagiwara M.

Proc Natl Acad Sci U S A. 2015 Mar 3;112(9):2764-9. doi: 10.1073/pnas.1415525112. Epub 2015 Feb 9.

8.

CDK9 inhibitor FIT-039 prevents replication of multiple DNA viruses.

Yamamoto M, Onogi H, Kii I, Yoshida S, Iida K, Sakai H, Abe M, Tsubota T, Ito N, Hosoya T, Hagiwara M.

J Clin Invest. 2014 Aug;124(8):3479-88. doi: 10.1172/JCI73805. Epub 2014 Jul 8.

9.

Decreased CaMKII and PKC activities in specific brain regions are associated with cognitive impairment in neonatal ventral hippocampus-lesioned rats.

Yabuki Y, Nakagawasai O, Moriguchi S, Shioda N, Onogi H, Tan-No K, Tadano T, Fukunaga K.

Neuroscience. 2013 Mar 27;234:103-15. doi: 10.1016/j.neuroscience.2012.12.048. Epub 2013 Jan 8.

PMID:
23313709
10.

Chronic fluvoxamine treatment changes 5-HT(2A/2C) receptor-mediated behavior in olfactory bulbectomized mice.

Oba A, Nakagawasai O, Onogi H, Nemoto W, Yaoita F, Arai Y, Tan-No K, Tadano T.

Life Sci. 2013 Feb 7;92(2):119-24. doi: 10.1016/j.lfs.2012.11.005. Epub 2012 Nov 15.

PMID:
23159642
11.

The kinase inhibitor SFV785 dislocates dengue virus envelope protein from the replication complex and blocks virus assembly.

Anwar A, Hosoya T, Leong KM, Onogi H, Okuno Y, Hiramatsu T, Koyama H, Suzuki M, Hagiwara M, Garcia-Blanco MA.

PLoS One. 2011;6(8):e23246. doi: 10.1371/journal.pone.0023246. Epub 2011 Aug 17.

12.

p-Hydroxyamphetamine causes prepulse inhibition disruption in mice: contribution of serotonin neurotransmission.

Onogi H, Nakagawasai O, Sato A, Mitazaki S, Nakaya K, Watanabe K, Niijima-Yaoita F, Tan-No K, Arai Y, Kikuchi T, Tadano T.

Behav Brain Res. 2011 Oct 10;224(1):159-65. doi: 10.1016/j.bbr.2011.06.002. Epub 2011 Jun 13.

PMID:
21689684
13.

Alpha1,6-fucosyltransferase-deficient mice exhibit multiple behavioral abnormalities associated with a schizophrenia-like phenotype: importance of the balance between the dopamine and serotonin systems.

Fukuda T, Hashimoto H, Okayasu N, Kameyama A, Onogi H, Nakagawasai O, Nakazawa T, Kurosawa T, Hao Y, Isaji T, Tadano T, Narimatsu H, Taniguchi N, Gu J.

J Biol Chem. 2011 May 27;286(21):18434-43. doi: 10.1074/jbc.M110.172536. Epub 2011 Apr 6.

14.

Pharmacological characterizations of memantine-induced disruption of prepulse inhibition of the acoustic startle response in mice: involvement of dopamine D2 and 5-HT2A receptors.

Nakaya K, Nakagawasai O, Arai Y, Onogi H, Sato A, Niijima F, Tan-No K, Tadano T.

Behav Brain Res. 2011 Mar 17;218(1):165-73. doi: 10.1016/j.bbr.2010.11.053. Epub 2010 Dec 3.

PMID:
21130810
15.

Development of a novel selective inhibitor of the Down syndrome-related kinase Dyrk1A.

Ogawa Y, Nonaka Y, Goto T, Ohnishi E, Hiramatsu T, Kii I, Yoshida M, Ikura T, Onogi H, Shibuya H, Hosoya T, Ito N, Hagiwara M.

Nat Commun. 2010 Oct 5;1:86. doi: 10.1038/ncomms1090.

PMID:
20981014
16.

Influence of olfactory bulbectomy on maternal behavior and dopaminergic function in nucleus accumbens in mice.

Sato A, Nakagawasai O, Tan-No K, Onogi H, Niijima F, Tadano T.

Behav Brain Res. 2010 Dec 20;215(1):141-5. doi: 10.1016/j.bbr.2010.07.012. Epub 2010 Jul 16.

PMID:
20638419
17.

p-Hydroxyamphetamine causes prepulse inhibition disruptions in mice: contribution of dopamine neurotransmission.

Onogi H, Nakagawasai O, Tan-No K, Mitazaki S, Sato A, Nakaya K, Niijima F, Arai Y, Kikuchi T, Tadano T.

Behav Brain Res. 2010 Dec 25;214(2):349-56. doi: 10.1016/j.bbr.2010.06.005. Epub 2010 Jun 9.

PMID:
20540968
18.

Inhibition of hepatitis C virus replication by a specific inhibitor of serine-arginine-rich protein kinase.

Karakama Y, Sakamoto N, Itsui Y, Nakagawa M, Tasaka-Fujita M, Nishimura-Sakurai Y, Kakinuma S, Oooka M, Azuma S, Tsuchiya K, Onogi H, Hagiwara M, Watanabe M.

Antimicrob Agents Chemother. 2010 Aug;54(8):3179-86. doi: 10.1128/AAC.00113-10. Epub 2010 May 24.

19.

Effect of non-selective dopaminergic receptor agonist on disrupted maternal behavior in olfactory bulbectomized mice.

Sato A, Nakagawasai O, Tan-No K, Onogi H, Niijima F, Tadano T.

Behav Brain Res. 2010 Jul 11;210(2):251-6. doi: 10.1016/j.bbr.2010.02.042. Epub 2010 Feb 26.

PMID:
20219556
20.

Behavioral and neurochemical characterization of mice deficient in the N-type Ca2+ channel alpha1B subunit.

Nakagawasai O, Onogi H, Mitazaki S, Sato A, Watanabe K, Saito H, Murai S, Nakaya K, Murakami M, Takahashi E, Tan-No K, Tadano T.

Behav Brain Res. 2010 Mar 17;208(1):224-30. doi: 10.1016/j.bbr.2009.11.042. Epub 2009 Dec 4.

PMID:
19963013
21.

Central administration of p-hydroxyamphetamine produces a behavioral stimulant effect in rodents: evidence for the involvement of dopaminergic systems.

Onogi H, Hozumi M, Nakagawasai O, Arai Y, Ishigaki S, Sato A, Furuta S, Niijima F, Tan-No K, Tadano T.

Psychopharmacology (Berl). 2010 Feb;208(2):323-31. doi: 10.1007/s00213-009-1734-x. Epub 2009 Dec 4.

PMID:
19960188
22.

Influence of memantine on brain monoaminergic neurotransmission parameters in mice: neurochemical and behavioral study.

Onogi H, Ishigaki S, Nakagawasai O, Arai-Kato Y, Arai Y, Watanabe H, Miyamoto A, Tan-no K, Tadano T.

Biol Pharm Bull. 2009 May;32(5):850-5.

23.

Subchronic stress-induced depressive behavior in ovariectomized mice.

Nakagawasai O, Oba A, Sato A, Arai Y, Mitazaki S, Onogi H, Wakui K, Niijima F, Tan-No K, Tadano T.

Life Sci. 2009 Apr 10;84(15-16):512-6. doi: 10.1016/j.lfs.2009.01.009. Epub 2009 Feb 3.

PMID:
19302813
24.

In vivo hepatocyte growth factor gene transfer reduces myocardial ischemia-reperfusion injury through its multiple actions.

Chen XH, Minatoguchi S, Kosai K, Yuge K, Takahashi T, Arai M, Wang N, Misao Y, Lu C, Onogi H, Kobayashi H, Yasuda S, Ezaki M, Ushikoshi H, Takemura G, Fujiwara T, Fujiwara H.

J Card Fail. 2007 Dec;13(10):874-83.

PMID:
18068622
25.

Modification of post-myocardial infarction granulocyte-colony stimulating factor therapy with myelo-suppressives.

Misao Y, Arai M, Ohno T, Ushikoshi H, Onogi H, Kobayashi H, Takemura G, Minatoguchi S, Fujiwara T, Fujiwara H.

Circ J. 2007 Apr;71(4):580-90.

26.

Edaravone reduces myocardial infarct size and improves cardiac function and remodelling in rabbits.

Onogi H, Minatoguchi S, Chen XH, Bao N, Kobayashi H, Misao Y, Yasuda S, Yamaki T, Maruyama R, Uno Y, Arai M, Takemura G, Fujiwara H.

Clin Exp Pharmacol Physiol. 2006 Nov;33(11):1035-41.

PMID:
17042911
27.

[Long-term results of chemoradiation therapy for the patients with locally advanced (T4) esophageal cancer].

Sekikawa K, Onogi H, Yazawa T, Sato Y, Sakamoto W, Miyamoto K, Fujita S, Suzuki S, Endo Y, Ohki S, Takenoshita S.

Gan To Kagaku Ryoho. 2006 Sep;33(9):1253-6. Japanese.

PMID:
16969020
28.

Importance of recruitment of bone marrow-derived CXCR4+ cells in post-infarct cardiac repair mediated by G-CSF.

Misao Y, Takemura G, Arai M, Ohno T, Onogi H, Takahashi T, Minatoguchi S, Fujiwara T, Fujiwara H.

Cardiovasc Res. 2006 Aug 1;71(3):455-65. Epub 2006 May 9.

PMID:
16769043
29.

Autologous bone marrow cell transplantation improves left ventricular function in rabbit hearts with cardiomyopathy via myocardial regeneration-unrelated mechanisms.

Lu C, Arai M, Misao Y, Chen X, Wang N, Onogi H, Kobayashi H, Uno Y, Takemura G, Minatoguchi S, Fujiwara T, Fujiwara H.

Heart Vessels. 2006 May;21(3):180-7.

PMID:
16715193
30.

[A case of recurrent gastric cancer effectively treated by combination chemotherapy of weekly paclitaxel and 5'- DFUR after showing resistance to weekly paclitaxel].

Suzuki S, Sekikawa K, Fujita S, Abe N, Ishigame T, Okada R, Gonda K, Saito M, Onogi H, Ohki S, Takenoshita S.

Gan To Kagaku Ryoho. 2006 Mar;33(3):385-7. Japanese.

PMID:
16531725
31.

Involvement of endoplasmic reticulum (ER) stress in podocyte injury induced by excessive protein accumulation.

Inagi R, Nangaku M, Onogi H, Ueyama H, Kitao Y, Nakazato K, Ogawa S, Kurokawa K, Couser WG, Miyata T.

Kidney Int. 2005 Dec;68(6):2639-50.

32.

[Two case reports on intra-tumor injection therapy of dendritic cells].

Kanazawa M, Yoshihara K, Abel H, Suzuki S, Endoh Y, Onogi H, Ohki S, Takita K, Sekikawa K, Takenoshita S, Takagi T, Irisawa A, Satoh Y, Ogata T, Ohto H.

Gan To Kagaku Ryoho. 2005 Oct;32(11):1571-3. Japanese.

PMID:
16315872
33.

Cilnidipine, an N+L-type dihydropyridine Ca channel blocker, suppresses the occurrence of ischemia/reperfusion arrhythmia in a rabbit model of myocardial infarction.

Nagai H, Minatoguchi S, Chen XH, Wang N, Arai M, Uno Y, Lu C, Misao Y, Onogi H, Kobayashi H, Takemura G, Maruyama R, Fujiwara T, Fujiwara H.

Hypertens Res. 2005 Apr;28(4):361-8.

PMID:
16138567
34.

ING2 regulates the onset of replicative senescence by induction of p300-dependent p53 acetylation.

Pedeux R, Sengupta S, Shen JC, Demidov ON, Saito S, Onogi H, Kumamoto K, Wincovitch S, Garfield SH, McMenamin M, Nagashima M, Grossman SR, Appella E, Harris CC.

Mol Cell Biol. 2005 Aug;25(15):6639-48.

35.

Novel serpinopathy in rat kidney and pancreas induced by overexpression of megsin.

Inagi R, Nangaku M, Usuda N, Shimizu A, Onogi H, Izuhara Y, Nakazato K, Ueda Y, Oishi H, Takahashi S, Yamamoto M, Suzuki D, Kurokawa K, van Ypersele de Strihou C, Miyata T.

J Am Soc Nephrol. 2005 May;16(5):1339-49. Epub 2005 Mar 23.

36.

[Verification of guideline for gastric cancer treatment based on a questionnaire].

Sekikawa K, Ohki S, Kohunato Y, Suzuki S, Ohshima T, Onogi H, Kanazawa M, Takenoshita S.

Gan To Kagaku Ryoho. 2004 Dec;31(13):2129-31. Japanese.

PMID:
15628757
37.

Accelerated glomerular injury in hemi-nephrectomized transgenic mice of mesangial cell-predominant serpin, megsin.

Onogi H, Inagi R, Nangaku M, Ueda Y, Miyata T, Kurokawa K.

Nephron Exp Nephrol. 2004;96(4):e127-33.

PMID:
15122062
38.

Manipulation of alternative splicing by a newly developed inhibitor of Clks.

Muraki M, Ohkawara B, Hosoya T, Onogi H, Koizumi J, Koizumi T, Sumi K, Yomoda J, Murray MV, Kimura H, Furuichi K, Shibuya H, Krainer AR, Suzuki M, Hagiwara M.

J Biol Chem. 2004 Jun 4;279(23):24246-54. Epub 2004 Mar 8.

39.

Regulation of binding of lamin B receptor to chromatin by SR protein kinase and cdc2 kinase in Xenopus egg extracts.

Takano M, Koyama Y, Ito H, Hoshino S, Onogi H, Hagiwara M, Furukawa K, Horigome T.

J Biol Chem. 2004 Mar 26;279(13):13265-71. Epub 2004 Jan 12.

40.

Proteomics and mesangial cell: serpin, megsin and plasmin.

Onogi H, Inagi R, Miyata T, Nangaku M, Kurokawa K.

Contrib Nephrol. 2004;141:212-20. Review. No abstract available.

PMID:
14650234
41.

p29ING4 and p28ING5 bind to p53 and p300, and enhance p53 activity.

Shiseki M, Nagashima M, Pedeux RM, Kitahama-Shiseki M, Miura K, Okamura S, Onogi H, Higashimoto Y, Appella E, Yokota J, Harris CC.

Cancer Res. 2003 May 15;63(10):2373-8.

42.

Affinity adsorption of glucose degradation products improves the biocompatibility of conventional peritoneal dialysis fluid.

Ishikawa N, Miyata T, Ueda Y, Inagi R, Izuhara Y, Yuzawa H, Onogi H, Nishina M, Nangaku M, Van Ypersele De Strihou C, Kurokawa K.

Kidney Int. 2003 Jan;63(1):331-9.

43.

Angiotensin II receptor antagonists and angiotensin-converting enzyme inhibitors lower in vitro the formation of advanced glycation end products: biochemical mechanisms.

Miyata T, van Ypersele de Strihou C, Ueda Y, Ichimori K, Inagi R, Onogi H, Ishikawa N, Nangaku M, Kurokawa K.

J Am Soc Nephrol. 2002 Oct;13(10):2478-87.

44.

Novel SR-rich-related protein clasp specifically interacts with inactivated Clk4 and induces the exon EB inclusion of Clk.

Katsu R, Onogi H, Wada K, Kawaguchi Y, Hagiwara M.

J Biol Chem. 2002 Nov 15;277(46):44220-8. Epub 2002 Aug 6.

45.

New attempt of preoperative differential diagnosis of thyroid neoplasms by telomerase activity measurement.

Suzuki S, Fukushima T, Ami H, Onogi H, Nakamura I, Takenoshita S.

Oncol Rep. 2002 May-Jun;9(3):539-44.

PMID:
11956624
46.

Overexpression of the serpin megsin induces progressive mesangial cell proliferation and expansion.

Miyata T, Inagi R, Nangaku M, Imasawa T, Sato M, Izuhara Y, Suzuki D, Yoshino A, Onogi H, Kimura M, Sugiyama S, Kurokawa K.

J Clin Invest. 2002 Mar;109(5):585-93.

47.

Glyoxalase I deficiency is associated with an unusual level of advanced glycation end products in a hemodialysis patient.

Miyata T, van Ypersele de Strihou C, Imasawa T, Yoshino A, Ueda Y, Ogura H, Kominami K, Onogi H, Inagi R, Nangaku M, Kurokawa K.

Kidney Int. 2001 Dec;60(6):2351-9.

48.

Cloning of human PRP4 reveals interaction with Clk1.

Kojima T, Zama T, Wada K, Onogi H, Hagiwara M.

J Biol Chem. 2001 Aug 24;276(34):32247-56. Epub 2001 Jun 19.

49.

Pre- and postoperative bone metabolism of primary hyperparathyroidism.

Suzuki S, Fukushima T, Ami H, Asahi S, Onogi H, Nakamura I, Tsuchiya A, Takenoshita S.

Biomed Pharmacother. 2000 Jun;54 Suppl 1:90s-96s.

PMID:
10915001
50.

Fatty acid synthase expression in Japanese breast carcinoma patients.

Nakamura I, Kimijima I, Zhang GJ, Onogi H, Endo Y, Suzuki S, Tuchiya A, Takenoshita S, Kusakabe T, Suzuki T.

Int J Mol Med. 1999 Oct;4(4):381-7.

PMID:
10493979

Supplemental Content

Support Center